On August 5, 2026, the Slovak competition authority (PMÚ) commenced proceedings to assess a concentration involving AGEL SK a.s. acquiring indirect exclusive control over Všeobecná nemocnica s poliklinikou Lučenec n.o.

This concentration falls within the healthcare sector, specifically under hospital activities and outpatient care.

The PMÚ invites third parties, including individuals and legal entities, to submit their comments, objections, and information regarding the announced concentration. They are encouraged to provide their feedback as soon as possible, ideally within one week of the announcement, to ensure that the authority can consider these inputs during the initial phase of the review.